Classical activation of macrophages and vardenafil

Abstract

Inhibitors of phosphodiesterase 5 (PDE5) - sildenafil citrate (Viagra; Pfizer) and vardenafil hydrochloride (Levitra; Bayer/GlaxoSmithKline) - approved for the treatment of erectile dysfunction and pulmonary arterial hypertension also rescue the loss of cystic fibrosis (CF) chloride channel function and the mislocalization of F508del-CFTR in affected tissues in CF. Can PDE5 inhibitors provide a therapeutic strategy which combines ability to correct the basic ion transport defect and to control de-regulated lung inflammation in CF?

Metadata

Authors/Creators:	Muimo, R. https://orcid.org/0000-0003-4242-0188
Copyright, Publisher and Additional Information:	© 2017 Portland Press. This is an author produced version of a paper subsequently published in Clinical Science. Uploaded in accordance with the publisher's self-archiving policy.
Keywords:	Immunology & Inflammation; Molecular Bases of Health & Disease; Molecular Interactions
Dates:	Accepted: 19 April 2017 Published (online): 22 May 2017 Published: June 2017
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease
Depositing User:	Symplectic Sheffield
Date Deposited:	14 Dec 2017 10:51
Last Modified:	03 Aug 2023 08:43
Status:	Published
Publisher:	Portland Press
Refereed:	Yes
Identification Number:	https://doi.org/10.1042/CS20170137
Related URLs:	Author

CORE (COnnecting REpositories)

Classical activation of macrophages and vardenafil

Abstract

Metadata

Download

Accepted Version

Export

Statistics